Vimseltinib
DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM) extracted from the patent WO2014145025A2 (Example 10) . (In Vitro) :DCC-3014 has anti-cancer and anti-proliferative activities.
Product Specifications
CAS Number
1628606-05-2
Product Name Alternative
DCC-3014
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 50 mg/mL (115.88 mM)
Smiles
CC (C) Nc1ncc (-c2ccc (Oc3ccnc (c3) -c3cnn (C) c3) c (C) n2) c (=O) n1C
Molecular Formula
C23H25N7O2
Molecular Weight
431.5
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
AE24105CA-01 48 Tests
Cat Beta-2 adrenergic receptor (ADRB2) ELISA Kit
Sign In for Pricing
View Details AE24105CA-02 96 Tests
Cat Beta-2 adrenergic receptor (ADRB2) ELISA Kit
Sign In for Pricing
View Details 
